中文名稱: 兔抗NAPSA多克隆抗體
英文名稱: Anti-NAPSA rabbit polyclonal antibody
別 名: KAP; Kdap; NAP1; NAPA; SNAPA
相關(guān)類別: 一抗
儲(chǔ) 存: 冷凍(-20℃)
抗 原: NAPSA
宿 主: Rabbit
反應(yīng)種屬: Human, Mouse
標(biāo) 記 物: Unconjugate
克隆類型: rabbit polyclonal
技術(shù)規(guī)格
Background: |
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. |
Applications: |
ELISA, WB, IHC |
Name of antibody: |
NAPSA |
Immunogen: |
Fusion protein of human NAPSA |
Full name: |
napsin A aspartic peptidase |
Synonyms: |
KAP; Kdap; NAP1; NAPA; SNAPA |
SwissProt: |
O96009 |
ELISA Recommended dilution: |
1000-5000 |
IHC positive control: |
Human liver cancer and Human gastric cancer |
IHC Recommend dilution: |
50-200 |
WB Predicted band size: |
45 kDa |
WB Positive control: |
mouse kidney tissue |
WB Recommended dilution: |
500-2000 |